A Study Of Resilience And Mental Well-Being Through Breathing Practice For Clinical Care Professionals
NCT ID: NCT07218458
Last Updated: 2025-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-10-27
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breathing Intervention
Engaging in self-guided breathing sessions to improve brain circulation and mental well-being.
Structured Breathing
15, 30, or 36 minute structured breathing sessions based on personal skill level.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Structured Breathing
15, 30, or 36 minute structured breathing sessions based on personal skill level.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must score ≥40 on Copenhagen Burnout Inventory Q1-6.
* Participants must be physically fit enough to perform light exercise.
* Participants should read and understand English well enough to consent, complete measures, and follow instructions.
* Participants must have access to a smartphone or tablet.
Exclusion Criteria
* Severe or unstable medical condition that could interfere with participation or data collection.
* Active neurological condition (including seizure disorder, traumatic brain injury, or stroke) that could affect cognitive functioning or brain imaging results.
* Chronic lung disease (e.g., COPD, cystic fibrosis) or aneurysm.
* Current pregnancy or planning to become pregnant during the study period
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pravesh Sharma
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pravesh Sharma, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic Health System-Albert Lea
Albert Lea, Minnesota, United States
Mayo Clinic Health System-Mankato
Mankato, Minnesota, United States
Mayo Clinic Health System-Eau Claire Clinic
Eau Claire, Wisconsin, United States
Mayo Clinic Health System-La Crosse
La Crosse, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Danielle Boos
Role: primary
Pravesh Sharma, MD
Role: backup
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25-009320
Identifier Type: -
Identifier Source: org_study_id